Metavia Inc (MTVA)

Jan 15, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Jan 15, 2025

Jan 13, 2025

NeuroBo Pharmaceuticals : Statement of Changes in Beneficial OwnershipForm 4 -July 28, 2022 at 09:34 pm EDT - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

2024 Initations - Zacks Small Cap Research

Jan 13, 2025

Jan 13, 2025

Zacks Small Cap Research 2024 Initiations and Best Ideas for 2025 - MSN

Jan 13, 2025

Jan 10, 2025

Biotech Advances Breakthrough Cancer Treatment Results - Streetwise Reports

Jan 10, 2025

Jan 10, 2025

MetaVia Advances Therapeutics with Promising Trial Updates - TipRanks

Jan 10, 2025

Jan 10, 2025

Walgreens tops Wall Street's expectations as drugstore chain continues turnaround plan - 69News WFMZ-TV

Jan 10, 2025

Jan 10, 2025

Greece bans windowless basements, freezes central Athens licenses in overhaul of short-term rentals - 69News WFMZ-TV

Jan 10, 2025

Jan 10, 2025

US added a strong 256,000 jobs in December as unemployment rate dipped to 4.1% - 69News WFMZ-TV

Jan 10, 2025

Jan 10, 2025

MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference - The Herald Journal

Jan 10, 2025

Jan 10, 2025

Childhood Smoking Ups COPD Risk - 69News WFMZ-TV

Jan 10, 2025

Jan 10, 2025

Advisory firm recommends changes at Air Products - 69News WFMZ-TV

Jan 10, 2025

Jan 10, 2025

Can Doctors Estimate Life Expectancy After a Dementia Diagnosis? - 69News WFMZ-TV

Jan 10, 2025

Jan 10, 2025

Stock market today: World shares slide further as rate cut, tariff worries hit market sentiment - 69News WFMZ-TV

Jan 10, 2025

Jan 10, 2025

Tanker hit by Houthi rebels that threatened a Red Sea oil spill has been salvaged - 69News WFMZ-TV

Jan 10, 2025

Jan 09, 2025

How the wildfires in the Los Angeles area could affect California's home insurance market - 69News WFMZ-TV

Jan 09, 2025

Jan 09, 2025

Meloni says Italy is exploring deals on telecoms security, but denies private talks with Musk - 69News WFMZ-TV

Jan 09, 2025

Jan 07, 2025

Revenue Surge & Breakthrough Margins Fuel Growth in Critical Care Tech - Streetwise Reports

Jan 07, 2025

Jan 06, 2025

Nearly half of Americans carry spare underwear for emergencies - 69News WFMZ-TV

Jan 06, 2025

Jan 05, 2025

‘Mufasa’ and ‘Sonic 3’ rule first weekend of 2025 - 69News WFMZ-TV

Jan 05, 2025

Jan 04, 2025

Pharma Innovator Unlocks Multi-Disease Treatment Potential - Streetwise Reports

Jan 04, 2025

Jan 03, 2025

Drug Innovator Launches Pivotal Cancer Trial Breakthrough - Streetwise Reports

Jan 03, 2025

Jan 02, 2025

Miami Biopharma Sells Part of Business & Begins New Clinical Trial - Streetwise Reports

Jan 02, 2025

Jan 02, 2025

What is HC Wainwright’s Estimate for MetaVia Q4 Earnings? - Defense World

Jan 02, 2025

Jan 01, 2025

Analysts Offer Predictions for MetaVia FY2024 Earnings - Defense World

Jan 01, 2025

Dec 31, 2024

Analyst Sees Major Growth for Biopharma With Weight-Loss Drug - Streetwise Reports

Dec 31, 2024

Dec 31, 2024

Analyst Initiates Coverage of Co. With 'Once-in-a-Generation' Drug - Streetwise Reports

Dec 31, 2024

Dec 31, 2024

MetaVia (NASDAQ:MTVA) Now Covered by Analysts at HC Wainwright - Defense World

Dec 31, 2024

Dec 30, 2024

MetaVia shares debut with Buy rating as DA-1726 shows preclinical weight-loss results - Investing.com Nigeria

Dec 30, 2024

Dec 30, 2024

This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Dec 30, 2024

Dec 23, 2024

American consumers feeling less confident in December, Conference Board says - 69News WFMZ-TV

Dec 23, 2024

Dec 20, 2024

MTVA: Compelling Data for DA-1241 in Phase 2a MASH Trial… - Zacks Small Cap Research

Dec 20, 2024

Dec 19, 2024

MetaVia to Participate in the 9th Annual MASH-TAG 2025 Conference After Releasing Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH - PR Newswire

Dec 19, 2024

Dec 18, 2024

MTVA stock touches 52-week low at $2 amid market challenges - Investing.com Australia

Dec 18, 2024

Dec 18, 2024

Clinical Trials News Live Feed - StockTitan

Dec 18, 2024

Dec 18, 2024

Artificial Intelligence (AI) News Live Feed - StockTitan

Dec 18, 2024

Dec 18, 2024

MetaVia Reports Positive Phase 2a Clinical Trial Results - TipRanks

Dec 18, 2024

Dec 18, 2024

MetaVia reports positive DA-1241 trial results for MASH - Investing.com

Dec 18, 2024

Dec 18, 2024

MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH - The Eastern Progress Online

Dec 18, 2024

Dec 17, 2024

NeuroBo Pharmaceuticals : Reports Third Quarter 2021 Financial ResultsForm 8-K - Marketscreener.com

Dec 17, 2024

Dec 17, 2024

Affimed stock plunges 23% on AFM24 study update (AFMD:NASDAQ) - Seeking Alpha

Dec 17, 2024

Dec 07, 2024

MTVA stock touches 52-week low at $2.04 amid market challenges - Investing.com Canada

Dec 07, 2024

Dec 06, 2024

MTVA stock touches 52-week low at $2.04 amid market challenges By Investing.com - Investing.com South Africa

Dec 06, 2024

Dec 04, 2024

NeuroBo Pharmaceuticals, Inc. announced that it expects to receive $10 million in funding - Marketscreener.com

Dec 04, 2024

Dec 04, 2024

Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now - The Manila Times

Dec 04, 2024

Dec 03, 2024

Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now - GlobeNewswire

Dec 03, 2024

Dec 02, 2024

NeuroBo Pharmaceuticals, Inc. announced that it expects to receive $15 million in funding from Dong-A ST Co., Ltd. - Marketscreener.com

Dec 02, 2024